InfoTechTarget and Informa Tech's Digital Businesses Combine.

Together, we power an unparalleled network of 220+ online properties covering 10,000+ granular topics, serving an audience of 50+ million professionals with original, objective content from trusted sources. We help you gain critical insights and make more informed decisions across your business priorities.

2021 University Research Week | READDI for the Next Pandemic

Presented by

University Research Week

About this talk

Employing expertise from UNC’s School of Medicine, the Gillings School of Global Public Health, and the Eshelman School of Pharmacy, the Rapidly Emerging Antiviral Drug Development Initiative (READDI), an open-science, nonprofit drug research and development organization, is creating “self-stable” antiviral therapeutics for each of the main virus families. The therapeutics will be poised for rapid development against new pandemic viruses as they emerge. READDI is the evolution of an interdisciplinary research known as the Infectious Disease Discovery Program at UNC (ID3@UNC), which was awarded funding through the Creativity Hubs initiative in 2019. Having a team already in place allowed the group to respond nimbly and quickly to the coronavirus outbreak and identify more partners to help in the fight against it. Master of Ceremonies: Matt Tremblay | Lead, Drug Discovery, Scripps Research Translational Institute and Chief Operating Officer, Scripps Research Featured Speakers: -Nat Moorman -Kenneth Pearce -Natalia Summerville
University of North Carolina at Chapel Hill

University of North Carolina at Chapel Hill

7442 subscribers17 talks
UNC Office of University Events
Content present by the UNC Chapel Hill Office of University Development and Office of University Events.
Related topics